Apc2tm1a(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Apc2tm1a(KOMP)Wtsi |
Name: |
APC regulator of WNT signaling pathway 2; targeted mutation 1a, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4363112 |
Gene: |
Apc2 Location: Chr10:80131811-80154097 bp, + strand Genetic Position: Chr10, 39.72 cM, cytoband B5-C2
|
Alliance: |
Apc2tm1a(KOMP)Wtsi page
|
IMPC: |
Apc2 gene page |
|
Mutant Cell Lines: |
EPD0122_5_A03, EPD0122_5_C03, EPD0150_5_A01, EPD0150_5_B02, EPD0150_5_C04, EPD0150_5_D01, EPD0150_5_D04, EPD0150_5_F01, EPD0150_5_F03, EPD0150_5_G01, EPD0150_5_H01 |
Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Conditional ready, Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 80140106 of Chromosome 10 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 80141701. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele can be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. If cre expression occurs without flp expression, a reporter knockout mouse will be created. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
3 reference(s) |
|